Sana Biotechnology (SANA) Accumulated Depreciation & Amortization (2020 - 2026)

Sana Biotechnology has disclosed Accumulated Depreciation & Amortization across 7 years of filings, most recently posting $57.1 million for Q1 2026.

• Accumulated Depreciation & Amortization for Q1 2026 came in at $57.1 million, changed 0.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $57.1 million (changed 0.33% YoY), and the FY2025 annual result was $54.8 million, up 1.09% from the prior year.
• Accumulated Depreciation & Amortization came in at $57.1 million for Q1 2026 at Sana Biotechnology, up from $54.8 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $57.3 million in Q1 2025 to a low of $22.4 million in Q1 2022.
• The 5-year median for Accumulated Depreciation & Amortization is $47.3 million (2023), against an average of $44.7 million.
• Across the five-year window, Accumulated Depreciation & Amortization surged 124.24% in 2022 and declined 0.33% in 2026, its largest moves.
• Sana Biotechnology's Accumulated Depreciation & Amortization stood at $34.0 million in 2022, then advanced by 22.94% to $41.8 million in 2023, then climbed by 29.67% to $54.2 million in 2024, then gained by 1.09% to $54.8 million in 2025, then increased by 4.37% to $57.1 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $57.1 million (Q1 2026), $54.8 million (Q4 2025), and $53.8 million (Q3 2025), per Business Quant data.